Gout affects around 9 million Americans, and around 50% of those with gout will have their first attacks begin in the big toe. The severity of gout will depend on the individual, but, on average, ...

Canakinumab Remarkably Effective in Gout The IL-1 beta inhibitor canakinumab produced rapid, sustained pain relief and fewer flares in gouty arthritis. Medscape Medical News, October 14, 2010 FDA ...